Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course

被引：3
作者：
Salmerón, J
Vivaldi, RM
De la Mata, M
Romero, M
Moreno, JP
Aguilar, J
Palacios, A
Nogueras, F
Vignote, M
Alcántara, R
Suarez, E
Andrade, R
Rodriguez, L
Sanchez, H
Quintero, D
机构：
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)81037-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
[21]   Retreatment of chronic hepatitis C in previous non-responders and relapsers [J].
Satoskar, Rohit ;
Jensen, Donald M. .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) :2491-2503
[22]   Treatment of chronic hepatitis c with consensus interferon in relapsers and non-responders to interferon-based therapy [J].
Steffen, M. ;
Cornberg, M. ;
Buggisch, P. .
HEPATO-GASTROENTEROLOGY, 2007, 54 (80) :2368-2372
[23]   Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial [J].
Ishida, H ;
Inoue, Y ;
Wong, JB ;
Okita, K .
HEPATOLOGY RESEARCH, 2004, 28 (03) :125-136
[24]   Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy [J].
Chousterman, N ;
Auray-Cartier, V ;
Hagege, H ;
Arpurt, JP ;
Cassan, P ;
Denis, J ;
Gargot, D ;
Nalet, B ;
Nouel, O ;
Pariente, A ;
Wartelle-Bladou, C .
HEPATOLOGY, 2002, 36 (04) :362A-362A
[25]   A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon. [J].
Kumar, KS ;
Malik, AH ;
Malet, PF ;
Ostapowicz, G ;
Wood, M ;
Jones, A ;
Lee, WM .
GASTROENTEROLOGY, 2000, 118 (04) :A1488-A1488
[26]   Cytokines in patients with chronic hepatitis C:: Comparison between responders and non-responders to interferon alfa2b. [J].
Fernández, JL ;
Silva, M ;
Eiras, G ;
Rendo, P ;
Pérez, V ;
Vidal, A ;
Criscuolo, M .
EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) :462-462
[27]   The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race [J].
De Maria, N ;
Colantoni, A ;
Idilman, R ;
Harig, J ;
Van Thiel, DH .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :1028-1029
[28]   Pegylated interferon alfa and ribavirin for children with chronic hepatitis C [J].
Irit Rosen ;
Michal Kori ;
Orly Eshach Adiv ;
Baruch Yerushalmi ;
Nataly Zion ;
Ron Shaoul .
World Journal of Gastroenterology, 2013, (07) :1098-1103
[29]   Pegylated interferon alfa and ribavirin for children with chronic hepatitis C [J].
Rosen, Irit ;
Kori, Michal ;
Adiv, Orly Eshach ;
Yerushalmi, Baruch ;
Zion, Nataly ;
Shaoul, Ron .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) :1098-1103
[30]   Interferon plus ribavirin re-treatment in hemophilic patients relapsers or non-responders to interferon alone. [J].
Rumi, M ;
Santagostino, E ;
Soffredini, R ;
Rivi, M ;
Gringeri, A ;
Colombo, M ;
Mannucci, PM .
HEPATOLOGY, 2000, 32 (04) :557A-557A
12345